MENLO PARK, Calif. --(BUSINESS WIRE)--Dec. 11, 2019-- Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 38 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at the Westin St. Francis Hotel in San Francisco , and will present at 1:30
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 19, 2019-- Intersect ENT, Inc. (NASDAQ: XENT ) today announced that management will participate in the 31 st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City , and will present in a session at
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 1, 2019-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today reported financial results for the third quarter ended September 30, 2019 .
MENLO PARK, Calif. --(BUSINESS WIRE)--Oct. 17, 2019-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release third quarter financial results on November 1, 2019 .
CMS Assigns New J Code for SINUVA and PROPEL, Effective October 1 MENLO PARK, Calif. --(BUSINESS WIRE)--Aug. 1, 2019-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today reported financial results for the second
MENLO PARK, Calif. --(BUSINESS WIRE)--Jul. 15, 2019-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release second quarter financial results on August 1, 2019 .
MENLO PARK, Calif. --(BUSINESS WIRE)--May 6, 2019-- Intersect ENT ® , Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today reported financial results for the first quarter ended March 31, 2019 .
